BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20237321)

  • 1. Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo.
    Krysov S; Potter KN; Mockridge CI; Coelho V; Wheatley I; Packham G; Stevenson FK
    Blood; 2010 May; 115(21):4198-205. PubMed ID: 20237321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins.
    Coelho V; Krysov S; Ghaemmaghami AM; Emara M; Potter KN; Johnson P; Packham G; Martinez-Pomares L; Stevenson FK
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18587-92. PubMed ID: 20937880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status.
    Mockridge CI; Potter KN; Wheatley I; Neville LA; Packham G; Stevenson FK
    Blood; 2007 May; 109(10):4424-31. PubMed ID: 17255355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chains.
    Vuillier F; Dumas G; Magnac C; Prevost MC; Lalanne AI; Oppezzo P; Melanitou E; Dighiero G; Payelle-Brogard B
    Blood; 2005 Apr; 105(7):2933-40. PubMed ID: 15591116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
    Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
    Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL.
    D'Avola A; Drennan S; Tracy I; Henderson I; Chiecchio L; Larrayoz M; Rose-Zerilli M; Strefford J; Plass C; Johnson PW; Steele AJ; Packham G; Stevenson FK; Oakes CC; Forconi F
    Blood; 2016 Aug; 128(6):816-26. PubMed ID: 27301861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi.
    Hoogeboom R; van Kessel KP; Hochstenbach F; Wormhoudt TA; Reinten RJ; Wagner K; Kater AP; Guikema JE; Bende RJ; van Noesel CJ
    J Exp Med; 2013 Jan; 210(1):59-70. PubMed ID: 23296468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
    Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
    J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural aspects of human IgM antibodies expressed in chronic B lymphocytic leukemia.
    Ramsland PA; Brock CR; Moses J; Robinson BG; Edmundson AB; Raison RL
    Immunotechnology; 1999 Mar; 4(3-4):217-29. PubMed ID: 10231091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 enhances expression and function of surface IgM in CLL cells.
    Aguilar-Hernandez MM; Blunt MD; Dobson R; Yeomans A; Thirdborough S; Larrayoz M; Smith LD; Linley A; Strefford JC; Davies A; Johnson PM; Savelyeva N; Cragg MS; Forconi F; Packham G; Stevenson FK; Steele AJ
    Blood; 2016 Jun; 127(24):3015-25. PubMed ID: 27002119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell receptor signaling in chronic lymphocytic leukemia.
    Stevenson FK; Krysov S; Davies AJ; Steele AJ; Packham G
    Blood; 2011 Oct; 118(16):4313-20. PubMed ID: 21816833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-linking of membrane IgM on B CLL cells.
    Grillot-Courvalin C; Hivroz C; Brouet JC
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):301-4. PubMed ID: 3146745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.
    Fais F; Ghiotto F; Hashimoto S; Sellars B; Valetto A; Allen SL; Schulman P; Vinciguerra VP; Rai K; Rassenti LZ; Kipps TJ; Dighiero G; Schroeder HW; Ferrarini M; Chiorazzi N
    J Clin Invest; 1998 Oct; 102(8):1515-25. PubMed ID: 9788964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations.
    Efremov DG; Ivanovski M; Batista FD; Pozzato G; Burrone OR
    J Clin Invest; 1996 Jul; 98(2):290-8. PubMed ID: 8755637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia.
    Stevenson FK; Forconi F; Packham G
    Semin Hematol; 2014 Jul; 51(3):158-67. PubMed ID: 25048780
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Maity PC; Bilal M; Koning MT; Young M; van Bergen CAM; Renna V; Nicolò A; Datta M; Gentner-Göbel E; Barendse RS; Somers SF; de Groen RAL; Vermaat JSP; Steinbrecher D; Schneider C; Tausch E; Bittolo T; Bomben R; Mazzarello AN; Del Poeta G; Kroes WGM; van Wezel JT; Imkeller K; Busse CE; Degano M; Bakchoul T; Schulz AR; Mei H; Ghia P; Kotta K; Stamatopoulos K; Wardemann H; Zucchetto A; Chiorazzi N; Gattei V; Stilgenbauer S; Veelken H; Jumaa H
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4320-4327. PubMed ID: 32047037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.
    Pal Singh S; de Bruijn MJW; de Almeida MP; Meijers RWJ; Nitschke L; Langerak AW; Pillai SY; Stadhouders R; Hendriks RW
    Front Immunol; 2018; 9():1996. PubMed ID: 30271400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients.
    Nédellec S; Renaudineau Y; Bordron A; Berthou C; Porakishvili N; Lydyard PM; Pers JO; Youinou P
    J Immunol; 2005 Mar; 174(6):3749-56. PubMed ID: 15749915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.
    Scielzo C; Ghia P; Conti A; Bachi A; Guida G; Geuna M; Alessio M; Caligaris-Cappio F
    J Clin Invest; 2005 Jun; 115(6):1644-50. PubMed ID: 15931393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.